Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Neurology
•
Child Neurology
•
Neurodevelopmental Disabilities
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
Related Questions
How do you counsel patients and caregivers on dietary interventions for autism?
What do you consider when clearing prophylactic anticoagulation in a pediatric patient with metastases in a dural venous sinus?
What is your approach to helping parents manage sleep disturbances in patients with autism spectrum disorder?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
Which interventions have you found effective for managing sensory sensitivities in children with autism spectrum disorder?
How do you assess efficacy when trialing a patient with Rett syndrome on trofinetide (Daybue)?
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
At what point should surgical intervention be considered for vestibular schwannomas or other tumors in pediatric NF2 patients?
What is the value of sending placental pathology in neonatal patients who have suffered an in-utero arterial ischemic stroke?
Which tools do you use to prognosticate recovery after respiratory cardiac arrest in children, as in drowning?
